This review is a summary of a presentation by Professor Arif Asif (New Jersey), which was given to haematologists and nephrologists in Sydney on Saturday 19th March 2016.
It discusses the pathophysiology, diagnosis, and treatment of atypical haemolytic uraemic syndrome, with emphasis on the role of biomarkers and the potential adverse consequences of discontinuing or deviating from recommended therapy.
Please login below to download this issue (PDF)